Literature DB >> 9140150

Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori.

C Martín-de-Argila1, D Boixeda, C Redondo, I Alvarez, J P Gisbert, A García Plaza, R Cantón.   

Abstract

BACKGROUND: Epidemiologic studies have consistently shown an association between Helicobacter pylori infection and gastric cancer, and it is now widely accepted that this organism plays a role in the pathogenesis of this tumor. Nevertheless, there are discrepant results on its relationship with the histologic type and location of gastric cancer within the stomach. The aim of this study was to determine the seroprevalence of H. pylori in a group of gastric cancer patients and the association between H. pylori and specific histologic types of gastric cancer and tumor location within the stomach.
METHODS: Systemic IgG antibodies against H. pylori were assayed using an enzyme-linked immunosorbent assay technique in 48 patients (male to female ratio, 31:17; age range, 39-88 years; mean, 69 years) with histologically confirmed gastric cancer and 50 controls (male to female ratio, 33:17; age range, 40-77 years, mean, 64 years).
RESULTS: Thirty-one cases of gastric cancer were of the intestinal type, and 12 of the diffuse type; the remaining 5 were unclassified. Thirteen gastric cancers were located in the distal stomach (antrum/pylorus), 12 in the body, and 5 in the proximal stomach (cardia/fundus); the remaining 17 were unclassified because the tumor extended towards more than one location. The overall seroprevalence of H. pylori in patients with gastric cancer and controls was 85.4% and 66%, respectively (P < 0.05). The seroprevalence increased with increasing age in cancer patients, but the difference was not significant. H. pylori seroprevalence among patients with the intestinal type of gastric cancer was higher than in those with the diffuse type (P < 0.05). The prevalence of H. pylori infection was higher among patients with the cancer located distally than in those with the cancer located proximally (P < 0.05).
CONCLUSIONS: H. pylori seroprevalence was higher in gastric cancer patients than in controls. The prevalence of H. pylori infection in intestinal-type gastric cancer was clearly higher than in the diffuse type and in the control group. An association was found between H. pylori infection and tumors located distally (antrum/pylorus).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9140150     DOI: 10.3109/00365529709007676

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

Review 1.  Diet, H pylori infection and gastric cancer: evidence and controversies.

Authors:  Alba Rocco; Gerardo Nardone
Journal:  World J Gastroenterol       Date:  2007-06-07       Impact factor: 5.742

Review 2.  Characteristics of gastric cancer in Asia.

Authors:  Rubayat Rahman; Akwi W Asombang; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

3.  Helicobacter pylori infection in patients with early gastric cancer by the endoscopic phenol red test.

Authors:  K Iseki; M Tatsuta; H Iishi; M Baba; S Ishiguro
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

4.  Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis.

Authors:  M C Camargo; G Murphy; C Koriyama; R M Pfeiffer; W H Kim; R Herrera-Goepfert; A H Corvalan; E Carrascal; A Abdirad; M Anwar; Z Hao; J Kattoor; E Yoshiwara-Wakabayashi; Y Eizuru; C S Rabkin; S Akiba
Journal:  Br J Cancer       Date:  2011-06-07       Impact factor: 7.640

5.  Overexpression of protein phosphatase non-receptor type 11 (PTPN11) in gastric carcinomas.

Authors:  Jin Soo Kim; Ok Ran Shin; Hyung Keun Kim; Young Seok Cho; Chang Hyeok An; Keun Woo Lim; Sung Soo Kim
Journal:  Dig Dis Sci       Date:  2009-08-19       Impact factor: 3.199

6.  Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran.

Authors:  R Malekzadeh; M Sotoudeh; M H Derakhshan; J Mikaeli; A Yazdanbod; S Merat; A Yoonessi; M Tavangar; B Ardakani Abedi; R Sotoudehmanesh; A Pourshams; A Ali Asgari; S Doulatshahi; B Ziad Alizadeh; S Arshi; A Madjidpoor; S Mir Moomen; D E Fleischer
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

7.  GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer.

Authors:  Dai Shimizu; Mitsuro Kanda; Haruyoshi Tanaka; Daisuke Kobayashi; Chie Tanaka; Masamichi Hayashi; Naoki Iwata; Yukiko Niwa; Hideki Takami; Suguru Yamada; Tsutomu Fujii; Goro Nakayama; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

Review 8.  Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options.

Authors:  Valli De Re; Giulia Brisotto; Ombretta Repetto; Mariangela De Zorzi; Laura Caggiari; Stefania Zanussi; Lara Alessandrini; Vincenzo Canzonieri; Gianmaria Miolo; Fabio Puglisi; Claudio Belluco; Agostino Steffan; Renato Cannizzaro
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.